Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grant R Sutherland

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Genomics|September 6, 2002
Sequencing, transcript identification, and quantitative gene expression profiling in the breast cancer loss of heterozygosity region 16q24.3 reveal three potential tumor-suppressor genesJason A Powell, Alison E Gardner, Anthony J Bais, et al.
The Journal of Biological Chemistry|December 10, 2003
HLS5, a novel RBCC (ring finger, B box, coiled-coil) family member isolated from a hemopoietic lineage switch, is a candidate tumor suppressorJean-Philippe Lalonde, Raelene Lim, Evan Ingley, et al.
Human Molecular Genetics|April 30, 2004
GABRD encoding a protein for extra- or peri-synaptic GABAA receptors is a susceptibility locus for generalized epilepsiesLeanne M Dibbens, Hua-Jun Feng, Michaella C Richards, et al.
Nature Genetics|March 13, 2002
Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsyPetter Strømme, Marie E Mangelsdorf, Marie A Shaw, et al.
Genomics|June 19, 2004
Folate-sensitive fragile site FRA10A is due to an expansion of a CGG repeat in a novel gene, FRA10AC1, encoding a nuclear proteinTheologia Sarafidou, Christina Kahl, Isabel Martinez-Garay, et al.
Cancer Research|August 17, 2002
CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3Marina Kochetkova, Olivia L D McKenzie, Anthony J Bais, et al.
Nature Genetics|May 13, 2008
X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairmentLeanne M Dibbens, Patrick S Tarpey, Kim Hynes, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Genomics|September 6, 2002
Sequencing, transcript identification, and quantitative gene expression profiling in the breast cancer loss of heterozygosity region 16q24.3 reveal three potential tumor-suppressor genesJason A Powell, Alison E Gardner, Anthony J Bais, et al.
The Journal of Biological Chemistry|December 10, 2003
HLS5, a novel RBCC (ring finger, B box, coiled-coil) family member isolated from a hemopoietic lineage switch, is a candidate tumor suppressorJean-Philippe Lalonde, Raelene Lim, Evan Ingley, et al.
Human Molecular Genetics|April 30, 2004
GABRD encoding a protein for extra- or peri-synaptic GABAA receptors is a susceptibility locus for generalized epilepsiesLeanne M Dibbens, Hua-Jun Feng, Michaella C Richards, et al.
Nature Genetics|March 13, 2002
Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsyPetter Strømme, Marie E Mangelsdorf, Marie A Shaw, et al.
Genomics|June 19, 2004
Folate-sensitive fragile site FRA10A is due to an expansion of a CGG repeat in a novel gene, FRA10AC1, encoding a nuclear proteinTheologia Sarafidou, Christina Kahl, Isabel Martinez-Garay, et al.
Cancer Research|August 17, 2002
CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3Marina Kochetkova, Olivia L D McKenzie, Anthony J Bais, et al.
Nature Genetics|May 13, 2008
X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairmentLeanne M Dibbens, Patrick S Tarpey, Kim Hynes, et al.
Pageof 2